Ena Respiratory is VC-Funded and has raised funding across Series B3 and Series B2 rounds. It is backed by Tess Property Holding and Um Commercialisation.
Alternatives.pe tracks Ena Respiratory's funding history, valuation trends, ownership structure, and transaction activity over time.
Last Updated: 2026-07-21
Explore the latest updates and insights
ENA Respiratory has raised US$22.4m (AU$34m) in Series B financing to support the phase 2 clinical ... see summary
ENA Respiratory Receives US$5m Investment from Flu Lab
A view of the number of employees over time
Grant
Grant
Brandon Capital announced the launch of Ena Respiratory Pty Ltd., which has developed a nasal ... see summary
Key members of the management team